查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853384

豬疫苗市場按疫苗類型、動物年齡、給藥途徑、包裝類型、最終用戶、疾病類型和分銷管道分類－全球預測，2025-2032年

Swine Vaccines Market by Vaccine Type, Animal Age, Route Of Administration, Packaging Type, End User, Disease Type, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，豬隻疫苗市場規模將成長 28.9 億美元，複合年成長率為 7.83%。

關鍵市場統計數據
基準年 2024 15.8億美元
預計年份：2025年 17億美元
預測年份 2032 28.9億美元
複合年成長率 (%) 7.83%

本書全面概述了現代豬疫苗接種策略如何在不斷發展的全球供應鏈中支撐豬群健康、生產韌性和農場層面的生物安全。

豬疫苗領域在動物健康、食品安全和農業經濟的交匯點上發揮著至關重要的作用。在現代生豬生產系統中，疫苗接種已從偶爾採取的干涉措施發展成為牛健康計畫的重要組成部分，旨在保護生產力、動物福利以及公眾對供應鏈的信任。集約化養殖、國際貿易以及病毒和細菌病原體的出現和再次出現所帶來的日益成長的壓力，進一步凸顯了製定強力的預防策略的必要性。因此，疫苗不再只是生物安全工具，而是直接影響農場韌性、抗菌藥物管理和長期永續性的戰略資產。

在農場之外，疫苗價值鏈涵蓋了生產商、經銷商、獸醫、診斷服務提供者和監管機構，他們之間的互動決定了技術創新對該領域的影響速度。先進分子平台、改進的遞送系統和數位健康工具的融合，使得更有針對性的疫苗接種方法成為可能。同時，生產者結構的變化、商業農場的整合以及消費者期望的轉變，都造成了複雜的營運環境。因此，相關人員必須平衡眼前的營運需求與中長期在研發、低溫運輸物流和培訓方面的投資，才能充分發揮疫苗接種作為現代豬隻健康管理基石的潛力。

科技、監管和商業性變革的整合如何將疫苗轉變為一種綜合解決方案，從而提高牛健康韌性和營運效率？

過去五年，隨著技術、監管和商業性動態的融合，豬隻疫苗生態系統經歷了加速變革，產業邊界也隨之重塑。在技​​術方面，新型抗原平台和佐劑技術的進步提高了疫苗的保護效力，同時減少了不良反應，並增強了疫苗與牛管理流程的兼容性。給藥途徑和包裝方式的改進也同步進行，降低了操作複雜性，並為大規模養殖中的群體免疫接種提供了更多實際選擇。病原體監測投入的增加進一步鞏固了這些技術進步，提高了疫苗株選擇的準確性，並縮短了從發現病原體到採取針對性應對措施的時間。

在商業性，策略夥伴關係和對生產能力的重點投資正在提升應對力應對區域需求波動和供應中斷的能力。監管機構正在提供更清晰的安全評估和現場有效性指導，鼓勵更嚴格的上市後監測和跨轄區標準的協調統一。同時，從低溫運輸遙測到牛層面的疫苗接種合規性追蹤，數位化正在提升可追溯性，並為獸醫和農場管理者提供更好的決策支援。總而言之，這些轉變正在將疫苗從單一產品交易轉變為一個整合解決方案，該方案結合了科學創新、營運支援和數據主導的洞察，從而大規模地保障牛健康。

評估2025年關稅對豬疫苗供應鏈和產業韌性的營運、採購和監管方面的連鎖影響

近期公佈的2025年關稅措施為豬疫苗供應鏈的相關人員帶來了新的複雜性，影響到原料、成品和跨境合作。這些關稅改變了進口零件和成品的實際成本結構，迫使製造商和委託製造製造商重新評估籌資策略和目前的生產分配。在許多情況下，這種調整加速了部分生產環節的在地化進程，或促使企業擺脫對單一國家的依賴，實現採購多元化。同時，經銷商物流面臨日益加劇的摩擦，需要重新談判商業條款並採取更靈活的庫存管理策略。

這些貿易變化不僅關乎成本和物流。區域監管協調和核准協議能夠減少合格評定中的重複工作，其策略價值日益凸顯。為此，一些公司正在加強與區域主管機關的合作，以簡化核准流程，並確保關鍵生物製劑的持續供應。在研發方面，關稅帶來的複雜性促使國內生產者與學術機構加強合作，以保護疫苗研發管線免受國際波動的影響。生產商優先研發劑量最少、操作更簡便的疫苗方案，而獸醫和供應商則強調制定完善的緊急時應對計畫，以應對不斷變化的貿易環境，保障疫苗接種計劃的持續開展。

透過對疫苗平台、動物年齡層、給藥途徑、包裝形式、目標疾病、最終用戶和分銷管道的詳細細分洞察，可以實現精準商業化。

深入分析市場細分，可以發現疫苗類型、動物年齡層、給藥途徑、包裝形式、最終用戶、目標疾病和分銷管道等方面的動態差異，這些差異對產品開發和商業化都有不同的影響。疫苗類型涵蓋DNA疫苗、去活化疫苗、減毒活疫苗、重組疫苗、次單位疫苗和減毒活病毒疫苗疫苗等多種平台，每種平台都具有獨特的風險效益特徵，影響著其在不同生產系統中的應用。動物年齡層包括種豬、育肥豬、生長豬、仔豬和離乳豬，其中種豬又進一步細分為公豬和母豬，它們各自具有特定的免疫窗口期和給藥策略，以保護繁殖性能和仔豬健康。

給藥途徑的選擇—注射、鼻腔給藥或口服給藥—會影響勞動力需求、動物壓力以及大規模疫苗接種的機會。包裝形式——多劑量瓶、預填充式注射器和管瓶——會影響低溫運輸需求、浪費率以及現場使用的便利性。最終用戶涵蓋商業農場、研究機構、獸醫院和診所，每個使用者群體都有不同的採購行為、合規要求和技術能力。特定疾病的疫苗包括豬瘟、豬丹毒、豬黴漿菌肺炎、豬環狀病毒、豬繁殖與呼吸症候群、豬流感。針對這些疾病的疫苗在免疫抗原性特徵和監管途徑的複雜性方面各不相同。分銷管道包括線上藥局、獸醫院和動物診所。線上藥局又可細分為企業網站和電子商務平台，這會影響行銷、履約和售後服務支援策略。這種細分能夠更細緻地確定研發投資的優先順序、客製化通訊方式，並使商業模式與最終用戶的實際情況相符。

區域對比分析重點闡述美洲、歐洲、中東和非洲以及亞太市場如何採取量身定做的疫苗研發、分發和監管策略。

豬疫苗的市場動態在成熟生產地區和新興市場之間存在顯著差異，這影響著產品設計、監管溝通和打入市場策略的優先事項。在美洲，集約化生產系統和一體化商業農場推動了對可擴展疫苗解決方案的需求，這些方案旨在最佳化勞動效率和群體免疫力。該地區重視穩健的供應鏈、可預測的監管流程以及強大的行業和獸醫關係，這些都有助於快速推廣有效的疫苗創新。

在歐洲、中東和非洲，監管的複雜性和多樣化的生產模式既帶來了挑戰，也帶來了機會。西歐市場強調嚴格的安全性和藥物安全檢測標準，而東歐、中東和非洲市場則往往需要成本效益高的配方和包裝，以適應規模較小的生產和不同的低溫運輸基礎設施。這種異質性支援模組化策略，將高效的平台與靈活的配送和包裝方案相結合。在亞太地區，密集的生產基地和反覆發生的疾病爆發正在加速新型疫苗技術和大規模接種方法的應用。契約製造的快速擴張和本地研發能力的提升，使該地區成為技術創新和區域供應安全的中心。在所有地區，數位化分銷管道和電子商務正在成為觸達獸醫專業人員和農民的補充途徑，尤其是在傳統分銷網路面臨結構性限制的地區。

產業領導者如何平衡平台創新、製造能力和策略夥伴關係，以確保競爭優勢並加速產品普及？

領先企業正以差異化的策略進軍豬隻疫苗領域，這些策略體現了其產品組合的專業化、地理重點和生技藥品生產能力。一些企業優先考慮平台多元化，投資新一代抗原技術和佐劑系統，以擴大對多種病原體的保護範圍，同時減少不利事件。另一些企業則專注於給藥途徑的創新和包裝改進，以降低大規模商業營運中的劑量複雜性和產品浪費。製造商與獸醫服務供應商之間的策略聯盟有助於彌合「最後一公里」差距，透過將培訓、診斷支援和現場監測整合到上市產品中，提高疫苗的普及率。

生產規模和滿足嚴格品質標準的能力是核心競爭優勢，靈活的製造外包安排也同樣重要，它能夠實現產能的快速擴張。嚴謹的智慧財產權管理和監管申報流程將決定新疫苗在不同核准時長地區的商業化速度。此外，越來越多的公司正與大學研究中心和公立獸醫學院合作，共用研發風險並加速轉化研究。這些綜合方法凸顯了該領域的成功取決於研發、卓越生產、監管策略和商業性執行的平衡發展。

為產業領導者提供切實可行的策略和營運建議，以增強疫苗創新、供應韌性和在生豬生產系統中的應用。

行業領導者應採取多管齊下的策略，將科學創新與切實可行的商業性和營運措施相結合，以加強疫苗推廣和市場韌性。首先，優先投資於能夠提供廣泛保護並快速適應新出現的病毒株的平台技術，可以獲得持久的競爭優勢。在研發重點之外，針對性地改進接種方法和包裝，可以減少現場操作中的阻力，並支持大規模疫苗宣傳活動。

其次，建立更具韌性的採購和生產策略至關重要。這包括實現關鍵投入品供應商多元化、擴大區域製造地，以及利用靈活的製造外包關係，即使在貿易中斷的情況下也能維持生產的連續性。第三，積極與監管機構溝通，透過明確資料預期並盡可能利用統一的核准途徑，可以縮短產品上市時間。第四，企業應加強與獸醫和農場服務提供者的夥伴關係，將疫苗接種納入包含診斷、數據分析和培訓在內的綜合牛健康計畫。最後，投資於供應鏈視覺化、低溫運輸監控和合規性追蹤的數位化工具，可以提高營運的可靠性，並提供可操作的數據來最佳化疫苗接種效果。這些措施共同構成了一條切實可行的藍圖，有助於提升產品的相關性、商業性吸引力和農場層面的實際效果。

本文清楚概述了一種混合方法研究途徑，該策略結合了深度訪談、文獻綜述、細分市場分析和專家檢驗，旨在得出可操作的見解。

本分析所依據的研究結合了定性和定量方法，以確保對疫苗價值鏈的各個環節進行全面、可靠的三角驗證。主要研究包括對獸醫、農民、生產商、經銷商和監管機構的專家進行結構化訪談，以了解實際經驗和策略重點。次要研究包括對科學文獻、監管指南、專利申請和生產系統分析進行系統性回顧，以識別技術和政策趨勢。這些研究成果透過三角分析方法進行整合，該方法協調了不同的觀點並檢驗了新出現的主題。

透過細分市場映射，將產品屬性與最終用戶需求、管理實際情況和通路相匹配。交叉驗證階段引入了獨立的專家評審小組，以檢驗假設並完善建議。調查方法的局限性透過記錄資料缺口和不確定性領域，並在定量精度有限的情況下強調定性影響來解決。倫理考量和保密通訊協定指導了訪談的開展以及專有資訊的去識別化。這些方法的結合建構了一個可靠且可操作的依證，旨在為研發、製造、監管和商業領域的決策提供資訊支援。

一份簡明扼要的綜述，重點闡述了將疫苗創新轉化為豬隻健康和生產韌性持續改善所需的策略重點和協作行動。

疫苗接種仍然是保護豬隻健康、維持生產連續性、維護大眾對豬肉供應鏈信任的最有效、擴充性的手段。豬肉產業正處於曲折點，科學進步、貿易動態變化和養殖方式的改變需要生產者、獸醫和政策制定者協調應對。成功與否取決於創新管道與實際供應機制的對接、增強區域生產和供應的韌性，以及深化將科學進步轉化為日常牛管理實踐的夥伴關係。

短期內，相關人員應著重採取營運措施以維持業務連續性，例如供應商多元化、最佳化庫存策略以及改善低溫運輸監控。中期來看，對適應性強的疫苗平台、精簡的監管策略以及擴大現場支援能力的投資，將決定哪些組織能夠在已開發市場和新興市場中主導。最終，能否將技術優勢轉化為可供不同終端使用者使用且切實可行的解決方案，將決定市場領導地位，更重要的是，還將推動動物健康和農場永續性的顯著改善。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 創新mRNA疫苗平台，用於頻譜豬流感預防
  • 採用針對豬繁殖與呼吸綜合症病毒和豬環狀病毒2型的單劑量聯合疫苗，以減輕養殖場的疫苗接種壓力
  • 擴大耐熱疫苗配方，以改善在新興的亞洲和拉丁美洲養豬市場的分銷
  • 整合重組病毒載體技術以加速對經典豬瘟的免疫反應
  • 引入一種農場快速診斷工具，以指導有針對性的豬疫苗接種通訊協定
  • 簡化主要生豬生產地區基因刪除減毒活疫苗的監管核准流程
  • 精準畜牧業投資趨勢：結合感測器數據和疫苗接種計劃，最佳化畜群健康
  • 公私合營推動針對新出現的豬冠狀病毒和流感病毒株的通用疫苗研究

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依疫苗類型分類的豬隻疫苗市場

  • DNA疫苗
  • 去活化疫苗
  • 減毒活疫苗
  • 重組疫苗
  • 次單位疫苗
  • 類毒素疫苗

9. 依動物年齡分類的豬隻疫苗市場

  • 育種者
    • 公豬
    • 母豬
  • 陳年豬肉
  • 生長豬
  • 小豬
  • 斷奶仔豬

第10章 依給藥途徑分類的豬隻疫苗市場

  • 注射
  • 鼻腔
  • 口服

第11章 豬疫苗市場依包裝類型分類

  • 多劑量瓶
  • 預填充式注射器
  • 管瓶

第12章 豬疫苗市場（依最終用戶分類）

  • 商業農場
  • 研究所
  • 獸醫診所
  • 獸醫診所

第13章 依疾病類型分類的豬隻疫苗市場

  • 豬霍亂
  • 丹毒
  • 肺炎黴漿菌
  • 豬環狀病毒
  • 豬繁殖與呼吸綜合症
  • 豬流感

第14章 豬隻疫苗市場依通路分類

  • 網路藥房
    • 公司網站
    • 電子商務平台
  • 獸醫診所
  • 獸醫診所

第15章 各地區豬疫苗市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 豬疫苗市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國豬疫苗市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim Animal Health GmbH
    • Elanco Animal Health Incorporated
    • Ceva Sante Animale SAS
    • Virbac SA
    • Vetoquinol SA
    • HIPRA, SA
    • Phibro Animal Health Corporation
    • IDT Biologika GmbH
Product Code: MRR-3A2E844FD486

The Swine Vaccines Market is projected to grow by USD 2.89 billion at a CAGR of 7.83% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.58 billion
Estimated Year [2025] USD 1.70 billion
Forecast Year [2032] USD 2.89 billion
CAGR (%) 7.83%

A compelling overview of how modern swine vaccination strategies underpin herd health, production resilience, and farm-level biosecurity across evolving global supply chains

The swine vaccines landscape occupies a pivotal role at the intersection of animal health, food security, and agricultural economics. In modern pork production systems, vaccination has evolved from an occasional intervention into an integral component of herd health programs that safeguard productivity, animal welfare, and public confidence in supply chains. Growing pressures from intensification, global trade, and the emergence and re-emergence of viral and bacterial pathogens have sharpened the need for robust preventive strategies. As a result, vaccines are not merely biosecurity tools but strategic assets that directly influence farm resilience, antimicrobial stewardship, and long-term sustainability.

Beyond farm gates, the vaccine value chain comprises manufacturers, distributors, veterinarians, diagnostic providers, and regulatory authorities whose interactions determine how rapidly innovations translate into field impact. The convergence of advanced molecular platforms, improved delivery systems, and digital health tools is enabling more targeted immunization approaches. At the same time, demographic shifts in producer profiles, consolidation among commercial farms, and shifting consumer expectations create a complex operating environment. Consequently, stakeholders must balance immediate operational demands with mid- to long-term investments in research, cold-chain logistics, and training to realize the full potential of vaccination as a cornerstone of modern swine health management.

How converging technological, regulatory, and commercial shifts are transforming vaccines into integrated solutions that enhance herd health resilience and operational efficiency

The past five years have witnessed accelerated change in the swine vaccines ecosystem as technological, regulatory, and commercial dynamics converge to reshape industry boundaries. On the technological front, novel antigen platforms and adjuvant science have advanced protective performance while reducing adverse reactions and improving compatibility with herd management routines. Parallel developments in administration routes and packaging have lowered handling complexity and expanded practical options for mass immunization in large-scale operations. These innovations have been reinforced by increasing investment in pathogen surveillance, which improves the precision of vaccine strain selection and shortens the time from detection to targeted response.

Commercially, strategic partnerships and targeted investments in manufacturing capacity have improved responsiveness to regional demand fluctuations and supply interruptions. Regulatory agencies have moved toward clearer guidance on safety evaluation and field efficacy, encouraging more rigorous post-market surveillance and harmonized standards across jurisdictions. Meanwhile, digitalization-ranging from cold-chain telemetry to herd-level vaccine compliance tracking-has enhanced traceability and decision support for veterinarians and farm managers. Collectively, these shifts are transforming vaccines from single-product transactions into integrated solutions that combine scientific innovation, operational support, and data-driven insights to secure herd health at scale.

Assessment of the cascading operational, sourcing, and regulatory consequences that 2025 tariff actions have imposed on swine vaccine supply chains and industry resilience

Recent tariff measures announced in 2025 have introduced a new layer of complexity for stakeholders in the swine vaccines supply chain, affecting inputs, finished products, and cross-border collaboration. As tariffs alter the effective cost structure for imported components and finished doses, manufacturers and contract producers have had to reassess sourcing strategies and near-term manufacturing allocations. In many cases, the adjustments have accelerated efforts to localize certain production steps or to diversify procurement away from single-country dependencies. At the same time, distributors and export-oriented suppliers face elevated friction in cross-border logistics, necessitating renegotiated commercial terms and more dynamic inventory management.

These trade shifts have implications beyond immediate cost and logistics. They have increased the strategic value of regional regulatory alignment and mutual recognition agreements that reduce duplication of conformity assessments. In response, several firms have intensified engagement with regional authorities to streamline approvals and maintain uninterrupted access to essential biological inputs. From a research perspective, tariff-driven complexity has also encouraged closer collaboration between domestic manufacturers and academic institutions to insulate vaccine pipelines from international volatility. For end users, the net effect has been a renewed focus on resilience: producers are prioritizing vaccine regimens that minimize administration frequency and simplify handling, while veterinarians and supply partners emphasize robust contingency planning to sustain immunization programs amid shifting trade conditions.

Detailed segmentation insights across vaccine platforms, animal age classes, administration routes, packaging configurations, disease targets, end users, and distribution channels informing targeted commercialization

A granular look at segmentation reveals differentiated dynamics across vaccine type, animal age category, administration route, packaging format, end user, disease focus, and distribution channels, each with distinct implications for product development and commercialization. Vaccine type diversity spans DNA vaccine, inactivated vaccine, live attenuated vaccine, recombinant vaccine, subunit vaccine, and toxoid vaccine platforms, and each platform presents a unique risk-benefit profile that influences adoption across production systems. Animal age segments include breeders, finishers, growers, piglets, and weaners, with breeders further differentiated into boars and sows, creating specific immunization windows and dosing strategies to protect reproductive performance as well as piglet health.

Administration route choices-between injection, nasal, and oral delivery-affect labor requirements, stress on animals, and opportunities for mass vaccination. Packaging type options, including multi dose bottle, pre filled syringe, and vial formats, determine cold-chain demands, wastage rates, and field usability. End users range from commercial farms to research institutes, veterinary clinics, and veterinary hospitals, and each category has different purchasing behaviors, compliance expectations, and technical capabilities. Disease-focused segmentation covers classical swine fever, erysipelas, mycoplasma pneumonia, porcine circovirus, porcine reproductive and respiratory syndrome, and swine influenza; vaccines targeted at these conditions vary in immunogenic profile and regulatory pathway complexity. Distribution channels include online pharmacies, veterinary clinics, and veterinary hospitals, with online pharmacies further segmented into company websites and e-commerce platforms, a distinction that influences marketing, fulfillment, and after-sales support strategies. Together, these segmentation lenses enable a more nuanced approach to prioritizing R&D investments, tailoring messaging, and aligning commercial models with end-user realities.

Comparative regional analysis clarifying how the Americas, Europe Middle East & Africa, and Asia-Pacific markets demand tailored vaccine development, distribution, and regulatory strategies

Regional dynamics in the swine vaccines arena differ markedly across established production zones and emerging growth markets, shaping priorities for product design, regulatory engagement, and market access strategies. In the Americas, high-intensity production systems and integrated commercial farms drive demand for scalable vaccination solutions that optimize labor efficiency and herd-level immunity. This region places a premium on robust supply chains, predictable regulatory processes, and strong industry-veterinarian relationships that support rapid uptake of validated vaccine innovations.

In Europe, Middle East & Africa, regulatory complexity and diverse production models create both challenges and opportunities. Western European markets emphasize stringent safety and pharmacovigilance standards, while segments in Eastern Europe, the Middle East, and Africa often require cost-effective formulations and packaging that accommodate smaller-scale operations and variable cold-chain infrastructure. This heterogeneity encourages modular strategies that combine high-efficacy platforms with adaptive delivery and packaging options. In the Asia-Pacific region, dense production hubs and recurring disease pressures accelerate adoption of novel vaccine technologies and mass-administration approaches. The rapid expansion of contract manufacturing and growing capabilities in local R&D institutions have made the region a focal point for both innovation and regional supply security. Across all regions, digital distribution channels and e-commerce are emerging as complementary pathways to reach veterinary professionals and farm managers, particularly where traditional distribution networks face structural constraints.

How leading industry players are balancing platform innovation, manufacturing capacity, and strategic partnerships to secure competitive advantage and accelerate product adoption

Leading corporate participants approach the swine vaccines space with differentiated strategies that reflect portfolio specialization, geographic focus, and capabilities in biologics manufacturing. Some firms prioritize platform diversification, investing in next-generation antigen technologies and adjuvant systems to broaden protection across multiple pathogens while reducing adverse events. Other organizations concentrate on route-of-administration innovations and packaging improvements to lower administration complexity and product wastage in large-scale commercial operations. Strategic alliances between manufacturers and veterinary service providers help bridge the final-mile gap and strengthen adoption by integrating training, diagnostic support, and field monitoring into commercial offerings.

Manufacturing scale and the ability to meet stringent quality standards are central competitive levers, as are flexible contract manufacturing arrangements that enable rapid capacity scaling. Intellectual property management and a disciplined approach to regulatory submissions determine how quickly new vaccines can be commercialized across regions with divergent approval timelines. Finally, an increasing number of companies are pursuing collaborative research with academic centers and public veterinary institutes to accelerate translational studies while sharing development risk. These combined approaches underscore that success in the sector depends on a balanced emphasis across R&D, manufacturing excellence, regulatory strategy, and commercial execution.

Practical strategic and operational recommendations that industry leaders can implement to enhance vaccine innovation, supply resilience, and adoption in swine production systems

Industry leaders should adopt a multi-pronged playbook that aligns scientific innovation with pragmatic commercial and operational measures to strengthen vaccine uptake and market resilience. First, prioritizing investments in platform technologies that enable broad-spectrum protection and rapid adaptability to emerging strains will yield durable competitive advantages. Complementing that R&D focus with targeted improvements in administration methods and packaging will reduce field friction and support mass vaccination campaigns.

Second, building more resilient sourcing and manufacturing strategies is essential. This includes diversifying key input suppliers, expanding regional manufacturing footprints, and using flexible contract manufacturing relationships to maintain continuity in times of trade disruption. Third, proactive regulatory engagement can shorten time-to-field by clarifying data expectations and leveraging harmonized approval pathways where available. Fourth, companies should expand partnerships with veterinarians and farm service providers to embed vaccination into comprehensive herd health programs that include diagnostics, data analytics, and training. Finally, investing in digital tools for supply-chain visibility, cold-chain monitoring, and compliance tracking will improve operational reliability and provide actionable data to optimize immunization outcomes. These steps, taken together, form an actionable roadmap to enhance product relevance, commercial traction, and farm-level impact.

Transparent overview of the mixed-method research approach that integrated primary interviews, literature synthesis, segmentation mapping, and expert validation to derive actionable insights

The research underpinning this analysis combined qualitative and quantitative techniques to ensure robust, triangulated insights across the vaccine value chain. Primary research included structured interviews with veterinarians, farm managers, manufacturers, distributors, and regulatory specialists to capture frontline experience and strategic priorities. Secondary research involved systematic review of scientific literature, regulatory guidance, patent filings, and production system analyses to contextualize technological and policy trends. These inputs were synthesized using a triangulation approach that reconciled disparate perspectives and validated emerging themes.

Segmentation mapping was applied to align product attributes with end-user needs, administration realities, and distribution pathways. A cross-validation stage incorporated independent expert review panels to challenge assumptions and refine recommendations. Methodological limitations were addressed by documenting data gaps and uncertainty ranges, and by emphasizing qualitative implications where quantitative precision was constrained. Ethical considerations and confidentiality protocols guided interview conduct and the anonymization of proprietary information. Together, these methods produced a defensible and actionable evidence base designed to inform decision-making across R&D, manufacturing, regulatory, and commercial domains.

Concise synthesis highlighting the strategic priorities and coordinated actions necessary for translating vaccine innovation into sustained improvements in swine health and production resilience

Vaccination remains the most effective and scalable tool to protect swine health, preserve production continuity, and support public confidence in the pork supply chain. The industry stands at an inflection point where scientific progress, shifting trade dynamics, and changing farm practices demand coordinated responses from manufacturers, veterinarians, and policy makers. Success will depend on aligning innovation pipelines with practical delivery mechanisms, strengthening regional manufacturing and supply resilience, and deepening partnerships that translate scientific advances into routine herd-level practices.

In the short term, stakeholders should focus on operational measures that preserve continuity-diversifying suppliers, optimizing inventory strategies, and improving cold-chain oversight. In the medium term, investments in adaptable vaccine platforms, streamlined regulatory strategies, and expanded field support capabilities will determine which organizations lead in both developed and emerging markets. Ultimately, the capacity to convert technical superiority into accessible, implementable solutions for diverse end users will define market leadership and, more importantly, drive measurable improvements in animal health and farm sustainability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Innovations in mRNA vaccine platforms for broad-spectrum swine influenza protection
  • 5.2. Adoption of single-dose combination vaccines targeting PRRS and porcine circovirus type 2 to reduce farm vaccination stress
  • 5.3. Expansion of thermostable vaccine formulations for improved distribution in emerging Asian and Latin American swine markets
  • 5.4. Integration of recombinant viral vector technologies to accelerate immune response against classical swine fever
  • 5.5. Implementation of on-farm rapid diagnostic tools to guide targeted swine vaccine administration protocols
  • 5.6. Regulatory approval pathways streamlining for gene-deleted live attenuated vaccines in major pork producing regions
  • 5.7. Investment trends in precision livestock farming combining sensor data with vaccination scheduling for optimized herd health
  • 5.8. Public-private partnerships driving research on universal vaccines against emerging porcine coronaviruses and influenza strains

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Swine Vaccines Market, by Vaccine Type

  • 8.1. Dna Vaccine
  • 8.2. Inactivated Vaccine
  • 8.3. Live Attenuated Vaccine
  • 8.4. Recombinant Vaccine
  • 8.5. Subunit Vaccine
  • 8.6. Toxoid Vaccine

9. Swine Vaccines Market, by Animal Age

  • 9.1. Breeders
    • 9.1.1. Boars
    • 9.1.2. Sows
  • 9.2. Finishers
  • 9.3. Growers
  • 9.4. Piglets
  • 9.5. Weaners

10. Swine Vaccines Market, by Route Of Administration

  • 10.1. Injection
  • 10.2. Nasal
  • 10.3. Oral

11. Swine Vaccines Market, by Packaging Type

  • 11.1. Multi Dose Bottle
  • 11.2. Pre Filled Syringe
  • 11.3. Vial

12. Swine Vaccines Market, by End User

  • 12.1. Commercial Farms
  • 12.2. Research Institutes
  • 12.3. Veterinary Clinics
  • 12.4. Veterinary Hospitals

13. Swine Vaccines Market, by Disease Type

  • 13.1. Classical Swine Fever
  • 13.2. Erysipelas
  • 13.3. Mycoplasma Pneumonia
  • 13.4. Porcine Circovirus
  • 13.5. Porcine Reproductive And Respiratory Syndrome
  • 13.6. Swine Influenza

14. Swine Vaccines Market, by Distribution Channel

  • 14.1. Online Pharmacies
    • 14.1.1. Company Websites
    • 14.1.2. E Commerce Platforms
  • 14.2. Veterinary Clinics
  • 14.3. Veterinary Hospitals

15. Swine Vaccines Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Swine Vaccines Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Swine Vaccines Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Zoetis Inc.
    • 18.3.2. Merck & Co., Inc.
    • 18.3.3. Boehringer Ingelheim Animal Health GmbH
    • 18.3.4. Elanco Animal Health Incorporated
    • 18.3.5. Ceva Sante Animale SAS
    • 18.3.6. Virbac S.A.
    • 18.3.7. Vetoquinol S.A.
    • 18.3.8. HIPRA, S.A.
    • 18.3.9. Phibro Animal Health Corporation
    • 18.3.10. IDT Biologika GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS SWINE VACCINES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL SWINE VACCINES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL SWINE VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. SWINE VACCINES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. SWINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SWINE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SWINE VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SWINE VACCINES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SWINE VACCINES MARKET SIZE, BY DNA VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SWINE VACCINES MARKET SIZE, BY INACTIVATED VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SWINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SWINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SWINE VACCINES MARKET SIZE, BY SUBUNIT VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SWINE VACCINES MARKET SIZE, BY TOXOID VACCINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SWINE VACCINES MARKET SIZE, BY BREEDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SWINE VACCINES MARKET SIZE, BY BOARS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SWINE VACCINES MARKET SIZE, BY SOWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SWINE VACCINES MARKET SIZE, BY FINISHERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SWINE VACCINES MARKET SIZE, BY GROWERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SWINE VACCINES MARKET SIZE, BY PIGLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SWINE VACCINES MARKET SIZE, BY WEANERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SWINE VACCINES MARKET SIZE, BY INJECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SWINE VACCINES MARKET SIZE, BY NASAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SWINE VACCINES MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SWINE VACCINES MARKET SIZE, BY MULTI DOSE BOTTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SWINE VACCINES MARKET SIZE, BY PRE FILLED SYRINGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SWINE VACCINES MARKET SIZE, BY VIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SWINE VACCINES MARKET SIZE, BY COMMERCIAL FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SWINE VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SWINE VACCINES MARKET SIZE, BY CLASSICAL SWINE FEVER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SWINE VACCINES MARKET SIZE, BY ERYSIPELAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SWINE VACCINES MARKET SIZE, BY MYCOPLASMA PNEUMONIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SWINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SWINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SWINE VACCINES MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SWINE VACCINES MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SWINE VACCINES MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SWINE VACCINES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS SWINE VACCINES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS SWINE VACCINES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE SWINE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE SWINE VACCINES MARKET SIZE, BY PACKAGING TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE SWINE VACCINES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE SWINE VACCINES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE SWINE VACCINES MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE SWINE VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE SWINE VACCINES MARKET SIZE, BY ONLINE PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 329. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY VACCINE TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2018-2024 (USD MILLION)
  • TABLE 334. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY ANIMAL AGE, 2025-2032 (USD MILLION)
  • TABLE 335. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY BREEDERS, 2018-2024 (USD MILLION)
  • TABLE 336. MIDDLE EAST SWINE VACCINES MARKET SIZE, BY BREEDERS, 2025-2032 (USD MILLION)
  • TABLE 337. MIDDLE EAST SWINE VACCIN